JB Therapeutics Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
2
- Latest Deal Type
-
M&A
JB Therapeutics General Information
Description
Provider of analgesic agents. The company develops therapeutics for the treatment of chronic peripheral pain and inflammation.
Contact Information
Website
www.jbtherapeutics.comCorporate Office
- One Kendall Square
- Building 200
- Cambridge, MA 02139
- United States
Corporate Office
- One Kendall Square
- Building 200
- Cambridge, MA 02139
- United States
JB Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 21-Apr-2014 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC | 10-Apr-2012 | Completed | Startup | |||
| 1. Grant | $244K | Completed | Startup |
JB Therapeutics Patents
JB Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2014127016-A2 | Ultrapure tetrahydrocannabinol-11-oic acids | Inactive | 12-Feb-2013 | ||
| WO-2012170290-A1 | Methods of treating fibrotic diseases using tetrahydrocannabinol-11-oic acids | Inactive | 04-Jun-2011 | ||
| WO-2012048045-A1 | Compositions, dosages, and methods of using tetrahydrocannabinol derivatives | Inactive | 05-Oct-2010 | ||
| US-20060128794-A1 | Therapy for bladder inflamamtion; administering by mouth, injection | Inactive | 13-Dec-2004 | ||
| US-20080182892-A1 | Therapy for bladder inflammation; administering by mouth, injection | Inactive | 13-Dec-2004 | A61K31/353 |
JB Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
JB Therapeutics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boston Harbor Angels | Angel Group | Minority | ||
| Boynton Angels | Angel Group | Minority | ||
| Mass Medical Angels | Angel Group | Minority |
JB Therapeutics Acquisitions (1)
JB Therapeutics’s most recent deal was a Reverse Merger with Corbus Pharmaceuticals Holdings. The deal was made on 03-Sep-2014.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings | 03-Sep-2014 | Reverse Merger | Drug Discovery |
JB Therapeutics FAQs
-
When was JB Therapeutics founded?
JB Therapeutics was founded in 2009.
-
Where is JB Therapeutics headquartered?
JB Therapeutics is headquartered in Cambridge, MA.
-
What is the size of JB Therapeutics?
JB Therapeutics has 2 total employees.
-
What industry is JB Therapeutics in?
JB Therapeutics’s primary industry is Drug Discovery.
-
Is JB Therapeutics a private or public company?
JB Therapeutics is a Private company.
-
What is JB Therapeutics’s current revenue?
The current revenue for JB Therapeutics is .
-
How much funding has JB Therapeutics raised over time?
JB Therapeutics has raised $662K.
-
Who are JB Therapeutics’s investors?
Boston Harbor Angels, Boynton Angels, and Mass Medical Angels have invested in JB Therapeutics.
-
When was JB Therapeutics acquired?
JB Therapeutics was acquired on 21-Apr-2014.
-
Who acquired JB Therapeutics?
JB Therapeutics was acquired by Corbus Pharmaceuticals Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
